Patients (N = 216) in NEOZOTAC | ||
---|---|---|
Median age, years (range) | 49.5 (28–70) | |
Median BMI, kg/m2 (range) | 26.2 (18.3–42.0) | |
Clinical T stage | cT1 or cT2 | 123 (56.9 %) |
cT3 or cT4 | 93 (43.1 %) | |
Clinical N stage | cN0 | 101 (46.8 %) |
cN+ | 115 (53.2 %) | |
Tumor type | Ductal | 128 (59.3 %) |
Lobular | 38 (17.6 %) | |
Other | 18 (8.4 %) | |
Unknown | 32 (14.8 %) | |
HR status | ER+ and/or PR+ | 180 (83.3 %) |
ER– and PR– | 36 (16.7 %) | |
Allocated treatment | TAC | 109 (50.5 %) |
TAC + ZA | 107 (49.5 %) | |
pCR breast and LN | Yes | 25 (11.6 %) |
No | 184 (85.2 %) | |
Unknown | 7 (3.2 %) | |
MP breast | 1 | 33 (15.3 %) |
2 | 56 (25.9 %) | |
3 | 41 (19.0 %) | |
4 | 42 (19.4 %) | |
5 | 35 (16.2 %) | |
Unknown | 9 (4.2 %) |